NEOGEN CHEMICALS enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


5,732	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
4.9	4.9	5.0	12.2	94.3
1,330	1,330	566	394	362
7,057	—	—	—	—
1,325	1,325	561	381	268
₹2,675.16	—	—	—	—

2,146	2,146	1,355	1,154	845
62.0%	62.0%	41.8%	34.1%	42.9%
0.19×	—	—	—	—

7.62×	—	—	—	—
45.82×	—	—	—	—
56.87×	—	—	—	—
926	862	778	691	686
154	138	136	110	112
124	110	109	87.2	95.4
—	−231	196	−29.2	−30.4
−787	−787	−122	−332	−134
—	−820	−136	−332	−143
—	556	318	303	104

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEOGEN₹2,172.90

NEOGEN CHEMICALS LTD.

· Chemicals

₹ CrorePeersTATACHEM AETHER NFL LXCHEM PRIVISCL RAIN RALLIS RCFMcap ₹5,732 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	5,732.1
- Cash, Equiv & ST Investments	94.3	12.2	5.0	4.9	4.9
+ Total Debt	362.2	393.5	566.0	1,329.9	1,329.9
Enterprise Value	—	—	—	—	7,057.1
Net Debt (memo)	267.9	381.3	561.1	1,325.0	1,325.0
EV per Share	—	—	—	—	2,675.16

Total Capital	844.7	1,153.8	1,355.4	2,146.1	2,146.1
Total Debt/Total Capital	42.88	34.11	41.76	61.97	61.97
Total Debt/EV	—	—	—	—	0.19

EV/Sales	—	—	—	—	7.62
EV/EBITDA	—	—	—	—	45.82
EV/EBIT	—	—	—	—	56.87
Reference Items — Trailing FY Values
Sales	686.2	690.7	777.6	862.0	925.5
EBITDA	111.6	110.1	136.3	137.6	154.0
EBIT	95.4	87.2	108.5	110.1	124.1
Operating Cash Flow	-30.4	-29.2	196.0	-231.5	—
Free Cash Flow	-134.1	-331.9	-121.7	-787.2	-787.2
FCFF (free cash flow to the firm)	-142.7	-332.4	-136.4	-819.9	—
Capital Expenditure	103.7	302.8	317.7	555.7	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.